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PENYINGKIRAN PARASETAMOL DAN TETRASIKLIN DARI AIR SISA 
SINTETIK MENGGUNAKAN FOTOPEMANGKIN HETEROGEN 
TiO2/SURIA 
  
ABSTRAK 
 
Parasetamol dan tetrasiklin terkenal dari segi penggunaan serta pengeluaran tahunan 
yang amat tinggi di seluruh dunia. Kehadiran kedua-dua bahan farmaseutikal ini di 
dalam pelbagai jenis sumber air telah dilaporkan di negara yang berlainan. Dalam 
kajian ini, pencirian air kumbahan telah membuktikan bahawa loji rawatan 
kumbahan konvensional berkesan dalam degradasi parameter konvensional ke tahap 
yang selamat, namun ia tidak berupaya untuk menyingkirkan sisa farmaseutikal 
(seperti parasetamol dan tetrasiklin) yang muncul di dalam air sisa kumbahan. Selain 
itu, kajian ini menyelidik keberkesanan proses rawatan fotopemangkin heterogen 
titanium dioksida [TiO2]/suria dalam penyingkiran parasetamol dan tetrasiklin dari 
air sisa sintetik secara berasingan. Kesan dari setiap pembolehubah yang dipilih 
(tempoh pendedahan terhadap cahaya matahari, pH, kepekatan TiO2 dan kepekatan 
farmaseutikal) dalam proses rawatan fotopemangkin telah dikenalpasti dengan 
menggunakan kaedah pemboleh ubah tunggal pada satu masa (SVAT). Hasil kajian 
menunjukkan bahawa semua pembolehubah yang dipilih mempengaruhi kecekapan 
penyingkiran parasetamol dan tetrasiklin. Seterusnya, rekaan pusat rencam (CCD) 
berdasarkan kaedah permukaan sambutan (RSM) telah digunakan untuk 
mengoptimumkan pembolehubah bagi kepekatan TiO2 dan farmaseutikal. 
Penyingkiran parasetamol sebanyak 82% diperolehi dalam keadaan optimum 1.0 g/L 
kepekatan TiO2 dan 0.06 g/L kepekatan parasetamol, manakala sebanyak 75% 
tetrasiklin telah disingkirkan dalam keadaan optimum 2.64 g/L kepekatan TiO2 dan 
xix 
0.07 g/L kepekatan tetrasiklin. Akhir sekali, kinetik degradasi fotopemangkin 
parasetamol dan tetrasiklin didapati mematuhi kinetik model Langmuir-Hinshelwood. 
Pemalar kadar (k) dan pemalar jerapan (K) dalam proses degradasi fotopemangkin 
parasetamol dan tetrasiklin masing-masing adalah 0.00052 g/L.min, 131.58 L/g dan 
0.0028 g/L.min, 71.43 L/g. Hasil kajian ini telah membuktikan kebolehpercayaan 
cahaya suria sebagai sumber UV semulajadi dalam proses degradasi fotopemangkin. 
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REMOVAL OF PARACETAMOL AND TETRACYCLINE FROM 
SYNTHETIC WASTEWATER USING HETEROGENEOUS TiO2/SOLAR 
PHOTOCATALYST 
 
ABSTRACT 
 
Paracetamol and tetracycline are well known with tremendous annual worldwide 
production and high global consumption rate. Their occurrence in the various water 
compartments has been reported in different countries. In this study, sewage 
characterization showed that the conventional wastewater treatment plant was 
effective to degrade the conventional parameters to the acceptable conditions, but it 
was unable to remove the pharmaceutical compounds (paracetamol and tetracycline) 
appeared in the sewage treatment plant (STP). Next, this study investigated the 
performance of heterogeneous photocatalysis titanium dioxide [TiO2]/solar treatment 
process in removing the paracetamol and tetracycline individually from the synthetic 
wastewater. In the batch study, the effects of the selected variables (sunlight 
exposure period, pH, TiO2 concentration and initial concentration of pharmaceutical) 
on the photocatalytic degradation efficiencies of paracetamol and tetracycline were 
investigated by using the single-variable-at-a-time (SVAT) method. Results showed 
that all of these selected factors greatly affected the removal efficiencies of 
paracetamol and tetracycline. Next, central composite design (CCD) based on the 
response surface methodology (RSM) were used to optimize the TiO2 and 
pharmaceutical concentrations. Under the optimum conditions of 1.0 g/L of TiO2 
concentration and 0.06 g/L of initial concentration of paracetamol, around 82% of 
paracetamol removal efficiency was attained, whereby, approximately 75% of 
tetracycline removal efficiency was achieved under the optimum conditions of 2.64 
xxi 
g/L of TiO2 concentration and 0.07 g/L of initial concentration of tetracycline. 
Finally, the kinetic of the photocatalytic degradation of paracetamol and tetracycline 
fitted well with the Langmuir-Hinshelwood kinetic model. The reaction rate constant 
(k) and adsorption constant (K) for the photocatalytic degradation process of 
paracetamol and tetracycline were 0.00052 g/L.min, 131.58 L/g and 0.0028 g/L.min, 
71.43 L/g, respectively. The results from these in situ experiments have proven the 
reliability of the solar in the photocatalysis treatment process. 
 
1 
CHAPTER ONE  
INTRODUCTION 
 
1.1 Background 
Water is one of the important resources on earth where human beings and 
ecological systems rely on it for survival. If there is no water, there will be no life on 
earth. Nowadays, the demand of water increases with the rapid growth of population 
and vigorous industrial development. High-quality water sources are necessary 
particularly in maintaining healthy ecosystems and assurance for safe drinking water. 
    In recent years, water pollution from the emerging contaminants of 
pharmaceuticals has been recognized as one of the most important aspects of 
environmental research (Borges et al., 2015). Pharmaceutical is one of the most 
indispensable elements with undeniable benefits in modern life. They are extensively 
and increasingly used as an integral component to establish and maintain a healthy 
population of both humans and livestock. However, due to the widespread 
application of pharmaceuticals and their inadequate removal from wastewater, low 
levels of pharmaceuticals (ranging from the low ng/L to mg/L) have been 
ubiquitously detected (in both original and metabolized forms) in various aquatic 
compartments such as surface water, groundwater, effluents of sewage treatment 
plant (STP), sea water and even in the drinking water (Cardoso et al., 2014).  
 The occurrence of the pharmaceutical compounds in the natural water 
sources has been reported as early in the year 1980 (Richardson and Bowron, 1985). 
Pharmaceuticals are known as the ―new emerging pollutants‖ (NEP) since they are 
recently detected in the environment in increasing amount and not covered by 
regulations until nowadays (Quadra et al., 2016; Sangion and Gramatica, 2016). The 
retained pharmaceuticals in different water sources may lead to some adverse effects 
2 
on the biological balance and human health such as aquatic toxicity, resistance 
development in pathogenic bacteria, acute and chronic damage, hormonal and 
endocrine disruption (K'oreje et al., 2016). This situation is getting even worse when 
these persistent pharmaceuticals are unable to be eliminated by using conventional 
wastewater treatment techniques due to the typical characteristics of the 
pharmaceuticals (Achilleos et al., 2010; Al-Odaini et al., 2013; Mozia and Morawski, 
2012). For example, pharmaceuticals which are lipophilic (tending to combine with 
or dissolve in lipids or fats) can easily pass through the membranes during the 
filtration process and facilitate the absorption. They can also escape from the 
biological treatment process since they are designed to be biologically active and 
persistent to maintain their therapeutic activity until the specific physiological 
function on the human and animals has been performed (Aguilar et al., 2011). 
Thereby, they have the properties to bioaccumulate and cause negative effects to 
aquatic or terrestrial ecosystems, such as immobilization, mortality, inhibition of 
growth and reproduction (Quadra et al., 2016). 
Other advanced treatment methods such as activated carbon adsorption, air 
stripping and reverse osmosis have also been investigated for the elimination of 
retained pharmaceuticals. Yet, studies have found out that these processes are less 
effective for the overall mineralization of pharmaceutical into the end product. This 
is due to the fact that those processes only transfer the pharmaceutical compounds 
from one phase to another or just collecting the pharmaceutical compounds without 
eliminating them (Elmolla and Chaudhuri, 2010b). The continuous input and 
persistence of pharmaceuticals in the aquatic ecosystem indicates an environmental 
challenge even their retained concentrations only range from the low ng/L to mg/L.     
